If that is the case, they think all the warrants holders are fool?
And Lawsuits will come infinitely.
Either data meet primary endpoint or doesn't meet primary endpoint. Answer should be simple and clear. There is no way to play wish-wash game with all the investors.
I think what you are trying to say ad hoc data mining you think wrong. Post hoc data mining does not exist post hoc rephrasing the trial questions aka the endpoints as stipulated in the SAP, based on the unblinded data, does.
I have not seen NWBO changing endpoints/the trial questions after the data was unblinded or even right after data lock was locked. You?
You have to invest a bit in time in how biotech analytics works to understand the difference.